Delix Therapeutics

Delix Therapeutics, a neuroscience company developing novel therapeutics for psychiatric and neurological conditions, announced Monday that it has raised over $30 million in a convertible note financing.  The fundraising round was led by existing investors, but also added new long-...

The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics to study a non-hallucinogenic version of the psychedelic drug ibogaine.   Collaboration with the National Institute...